Annovis Bio, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.5M | $46.0M | $45.7M |
| FY2022 | $1.4M | $44.1M | $42.7M |
| FY2023 | $18.0M | $10.2M | $5.8M |
| FY2024 | $4.6M | $13.9M | $10.6M |
| FY2025 | $4.2M | $21.1M | $19.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.5M | $46.0M | $45.7M |
| FY2022 | $1.4M | $44.1M | $42.7M |
| FY2023 | $18.0M | $10.2M | $5.8M |
| FY2024 | $4.6M | $13.9M | $10.6M |
| FY2025 | $4.2M | $21.1M | $19.5M |